Living Donation and Kidney Transplantation Information

Kidney Transplantation Clinical Trial

— KIDNEYTIME  

Official title:

Living Donation and Kidney Transplantation Information Made Easy (KIDNEYTIME) With Animated Video Education

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04285203
• Other study ID #: STUDY00002771
• Status: Completed
• Phase: N/A
• Start date: April 8, 2019
• Est. completion date: February 10, 2020

Study information

• Verified date: February 2020
• Source: State University of New York at Buffalo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to increase awareness and knowledge regarding the risks and benefits of kidney transplantation and living donation amongst patients seeking kidney transplantation and their family and friends in Buffalo, New York.

Description:

This prospective randomized parallel controlled trial of kidney transplant candidates receiving and educational intervention and standard of care education versus standard of care education only to improve informed decision making about kidney offers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 144
• Est. completion date: February 10, 2020
• Est. primary completion date: August 29, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• be 18 years or older,

• understand and read English (or have a support person that helps them)

• have acceptable vision to watch videos

• be able to give consent

Exclusion Criteria:

• incarcerated

• involved in the former modeling phase of animation development.

Related Conditions & MeSH terms

• Kidney Transplantation

Intervention

Other:
• Educational Video Intervention
Educational videos

Locations

Country	Name	City	State
United States	Erie County Medical Center	Buffalo	New York

Sponsors (1)

Lead Sponsor	Collaborator
State University of New York at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in knowledge	Assessed by knowledge survey pre and post exposure.	Baseline and immediately post exposure
Primary	Change in attitude about kidney offers	Assessed by attitude survey pre and post exposure.	Baseline and immediately post exposure
Secondary	Change in subjective decisional self-efficacy	Assessed by self-efficacy survey pre and post exposure.	Baseline and immediately post exposure
Secondary	Participation and decision making	Number of questions and value statements in regards to organ offers.	1 day (During standard of care education at time of clinic visit)